StudyGraphics #VisualAbstract Lenalidomide shows improvement in progression-free survival over bortezomib maintenance following autologous stem cell transplantation for multiple myeloma January 28, 2021 | Kathleen Lau Facebook Twitter Pinterest WhatsApp Linkedin ReddIt Email Print RELATED ARTICLESMORE FROM AUTHOR #VisualAbstract Addition of daratumumab to standard of care improves minimal residual disease negativity in patients with newly diagnosed, transplant-ineligible multiple myeloma #VisualAbstract Menopausal hormone therapy was not associated with risk of cutaneous melanoma #VisualAbstract: Sentinel lymph node-guided neck dissection is noninferior to elective dissections for patients with early oral cavity squamous cell carcinoma
